• search

Cadila gets tentative FDA approval for Carvedilol

Written by: Staff

New Delhi, Mar 13 (UNI) Drug maker Cadila Healthcare Ltd, part of the Zydus Cadila group, today said it had received tentative approval from the US Food and Drug Administration (USFDA) to market its cardiovascular drug Carvedilol tablets.

The drug is used to treat heart failure and high blood pressure.

The current sale of Carvedilol tablets in the US market as per NDC Health is estimated at 1.24 billion dollars, Cadila said in a statement.

The group had recently received the tentative approval to market Sertraline Hydrochloride Tablets, 25 mg, 50 mg and 100 mg, in the US market.


For Daily Alerts

For Breaking News from Oneindia
Get instant news updates throughout the day.

Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more